KDR and neoplasm: Finally, AAV serotype 8 vectors overexpressing both soluble VEGFR2 and VEGFR3 receptors combined with paclitaxel and carboplatin resulted in strong anti-angiogenic and anti-tumor effects in the treatment of ovarian cancer [175].